Is Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) Still On The Rise?

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $422.78 and fluctuated between $400.14 as its day high and $393.76 as its day low. The current market capitalization of Vertex Pharmaceuticals, Inc. is $109.10B. A total of 1.06 million shares were traded on the day, compared to an average of 1.04M shares.

In the most recent transaction, Bhatia Sangeeta N. sold 467 shares of VRTX for 402.95 per share on May 02 ’24. After the transaction, the Director now owns 4,435 company shares. In a previous transaction on Apr 02 ’24, Ambrose Kristen sold 240 shares at 419.00 per share. VRTX shares that SVP & Chief Accounting Officer owns now total 7,500.

Among the insiders who sold shares, Arbuckle Stuart A disposed of 5,034 shares on Feb 26 ’24 at a per-share price of $425.70. This resulted in the EVP, COO holding 49,691 shares of VRTX after the transaction. In another insider transaction, ALTSHULER DAVID sold 4,239 shares at $425.70 per share on Feb 26 ’24. Company shares held by the EVP, Global Research and CSO now total 25,813.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, VRTX has a high of $448.40 and a low of $320.01.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. VRTX’s latest balance sheet shows that the firm has $7.52B in Cash & Short Term Investments as of fiscal 2021. There were $967.40M in debt and $2.14B in liabilities at the time. Its Book Value Per Share was $71.80, while its Total Shareholder’s Equity was $10.10B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRTX is Buy with a score of 4.13.

Most Popular

Related Posts